Core Viewpoint - The merger and acquisition plan of China Nuclear Technology has been terminated due to changes in market conditions and the actual situation of the target company, which were different from the initial planning stage [2][3]. Group 1: Transaction Details - China Nuclear Technology announced the termination of the share issuance for asset acquisition and related fundraising on July 7 [2]. - The original plan involved acquiring 100% of the shares of China Nuclear Western Instrumentation from various stakeholders, including China Nuclear Engineering and Guohua Development [2]. - The transaction was expected to constitute a significant asset restructuring, enhancing the integration of resources within the nuclear equipment manufacturing sector [3]. Group 2: Financial Performance of Target Company - China Nuclear Western Instrumentation reported revenues of 1.149 billion, 1.324 billion, and 663 million for the years 2022, 2023, and the first nine months of 2024, respectively [3]. - The net profits for the same periods were 177 million, 164 million, and approximately 81.6 million [3]. Group 3: Company Communication and Future Plans - China Nuclear Technology stated that the decision to terminate the transaction was made after careful consideration and communication with the counterparties, ensuring no adverse impact on the company's operations or financial status [3]. - An investor briefing will be held on July 10 to discuss the termination of the transaction and engage with investors [4].

Core Viewpoint - China Nuclear Technology announced the termination of the transaction to acquire 98.87% of Xi'an China Nuclear Instrument Co., Ltd. due to changes in market conditions and the actual situation of the target company [1][6][10] Group 1: Transaction Details - The planned transaction was expected to constitute a major asset restructuring and related party transaction, aligning with the industry's trend of enhancing competitiveness through mergers and acquisitions [1][6] - The transaction was part of China Nuclear Group's strategy to inject quality assets into its listed companies, with both China Nuclear Technology and Xi'an China Nuclear Instrument being controlled by China Nuclear Group [1][5] - The transaction involved multiple parties, including China Nuclear Power Engineering Co., Ltd. and various investment funds, all under the control of China Nuclear Group [3][5] Group 2: Financial Data - As of September 30, 2024, China Nuclear Technology reported total assets of 2.663 billion yuan and net assets of 1.491 billion yuan [2] - The company's revenue for 2022, 2023, and the first three quarters of 2024 were 1.149 billion yuan, 1.324 billion yuan, and 663 million yuan, respectively, with net profits of 177 million yuan, 164 million yuan, and 81.6 million yuan [1][2] - The total liabilities as of September 30, 2024, were 1.172 billion yuan, with total equity of 1.491 billion yuan [2] Group 3: Strategic Implications - The termination of the transaction is seen as a setback for China Nuclear Technology, which aimed to enhance its strength and core competitiveness in the nuclear equipment manufacturing sector [6][7] - Xi'an China Nuclear Instrument is recognized as a key supplier in the nuclear industry, specializing in radiation monitoring systems and other safety systems, indicating its strong market position [6] - The company had anticipated that the transaction would improve its profitability and investment value, aligning with industry development trends [7]

Core Viewpoint - China Nuclear Technology has decided to terminate the major asset restructuring plan due to changes in market conditions and the actual situation of the target company, Xi'an China Nuclear Instrument Co., Ltd. [2][7] Group 1: Company Overview - China Nuclear Technology announced the termination of the transaction to acquire 98.87% of Xi'an China Nuclear Instrument Co., Ltd. and raise matching funds, which was expected to constitute a major asset restructuring and related party transaction [5][7]. - The transaction was part of a strategy by China National Nuclear Corporation (CNNC) to inject quality assets into its listed companies, enhancing competitiveness through mergers and acquisitions [5][6]. Group 2: Financial Data - As of September 30, 2024, China Nuclear Technology reported total assets of 2.663 billion yuan and net assets of 1.491 billion yuan [7]. - The operating revenues for 2022, 2023, and the first three quarters of 2024 were 1.149 billion yuan, 1.324 billion yuan, and 663 million yuan, respectively, with net profits of 177 million yuan, 164 million yuan, and 81.6 million yuan [7][16]. Group 3: Market Environment - The decision to terminate the transaction was influenced by changes in the market environment and the actual conditions of Xi'an China Nuclear Instrument Co., Ltd. since the initial planning of the transaction [7][14]. - The restructuring was seen as a way to strengthen the competitive position of companies in the nuclear industry, which is experiencing a trend towards consolidation among leading firms [18]. Group 4: Strategic Implications - The termination of the transaction means that the expected benefits, such as enhancing core competitiveness in the nuclear equipment manufacturing sector, will not be realized [15][16]. - The planned fundraising was intended to cover transaction-related taxes and fees, support project construction, and improve liquidity for both China Nuclear Technology and Xi'an China Nuclear Instrument Co., Ltd. [13][14]. Group 5: Stock Performance - As of July 7, the stock price of China Nuclear Technology was 21.72 yuan per share, with a total market capitalization of 8.328 billion yuan [19].